North America Systemic Aspergillosis and Systemic Candidasis Market Dynamics and Trends by 2027
North America Systemic Aspergillosis and Systemic Candidasis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ( Voriconazole, Liposomal, Amphotericin B, Systemic Oral Azoles, Topical, Antifungal Agents, and Others ); Application ( Chronic, Pulmonary Aspergillosis (CPA), Allergic, Bronchopulmonary Aspergillosis (ABPA), Gastrointestinal Candidiasis, Genitourinary Tract Candidiasis, and Others ); and Country
- Report Date : Mar 2021
- Report Code : TIPRE00020066
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 127
The Systemic Aspergillosis and Systemic Candidasis market in North America is expected to grow from US$ 2,423.82 million in 2019 to US$ 3,352.62 million by 2027. This represents a CAGR of 4.2% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to rise in prevalence of fungal diseases, rising hospital acquired fungal infection. Additionally, presence of major players and well-developed regulatory policies are projected to drive the North American systemic aspergillosis and systemic candidasis market during the forecast period.
Candida Auris is a fungus that causes a serious global health threat. C. Auris causes severe illness in hospitalized patients in several countries, including the United States. Patients can remain colonized with C. Auris for a long time, and C. Auris can persist on surfaces in healthcare environments. This can result in the spread of C. Auris between patients in healthcare facilities. According to a CDC report of 2021, U.S. cases of C. Auris have been found in patients who had recent stays in healthcare facilities in Egypt, India, Kenya, Kuwait, Pakistan, South Africa, South Korea, the United Arab Emirates, and Venezuela, which also have documented cases. Thus, this can be a hospital-acquired infection. The emergence of Candida Auris is considered as one of the most serious problems associated with nosocomial transmission and with infection control practices in the hospital environment. Moreover, Centers for Disease Control and Prevention (CDC) stated,560 cases of C. auris infections have been notified in the United States as 31 January 2019. Furthermore, execution of countermeasures to limit fungal infections in intensive care units (ICUs), cases continue to be reported, with a tendency to an endemic pattern. This reflects the ability of C. auris to persist in clinical environment, enabling its transmission within critical care setting. Other than Candida species, C. auris can colonize different anatomical sites (e.g., skin, axilla, rectum, stool) and contaminate the hospital equipment and surfaces, creating a vicious cycle of spreading, acquisition, and infection, particularly in ICUs.
Additionally, according to the NCBI report published in Jan 2020, the Increasing number of travels to foreign countries and exposure to healthcare in countries with extensive C. Auris transmission, as well as the higher flow of migrants, are factors that can contribute to the quick dissemination of this species. Further, a higher frequency of C. Auris was found in public hospitals in comparison to the private ones, which may be connected to overcrowding and compromised infection control measures.
US Systemic Aspergillosis and Systemic Candidasis Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA SYSTEMIC ASPERGILLOSIS AND SYSTEMIC CANDIDASIS – MARKET SEGMENTATION
By Type
- Systemic Oral Azoles
- Voriconazole
- Liposomal Amphotericin B
- Topical Antifungal Agents
- Others
By Application
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Chronic Pulmonary Aspergillosis (CPA)
- Gastrointestinal Candidiasis
- Genitourinary Tract Candidiasis
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Novartis AG
- Sanofi
- Pfizer Inc.
- Merck & Co., Inc.
- Bayer AG
- Astellas Pharma Inc.
- GlaxoSmithKline plc.
- Abbott
- Cipla Inc.
- Enzon Pharmaceuticals, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Systemic Aspergillosis and Systemic Candidasis Market – By Type
1.3.2 North America Systemic Aspergillosis and Systemic Candidasis Market – By Application
1.3.3 North America Systemic Aspergillosis and Systemic Candidasis Market – By Country
2. Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
4.4 Clinical Trials Phases of Products Offered by Companies
4.5 Candida Specific Products
5. Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Fungal Diseases
5.1.2 Rising Hospital Acquired Fungal Infection
5.2 Market Restraints
5.2.1 Increasing Resistance to Antifungal Drugs
5.2.2 Side Effects of Antifungal Drugs
5.3 Market Opportunities
5.3.1 Increase in R&D Activities and Pipeline of New Drug
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type
6.1 Overview
6.2 North America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
6.3 Voriconazole
6.3.1 Overview
6.3.2 North America Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Liposomal Amphotericin B
6.4.1 Overview
6.4.2 North America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Systemic Oral Azoles
6.5.1 Overview
6.5.2 North America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
6.6 Topical Antifungal Agents
6.6.1 Overview
6.6.2 North America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
6.7 Others
6.7.1 Overview
6.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
7. Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application
7.1 Overview
7.2 North America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
7.3 Chronic Pulmonary Aspergillosis (CPA)
7.3.1 Overview
7.3.2 North America Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Allergic Bronchopulmonary Aspergillosis (ABPA)
7.4.1 Overview
7.4.2 North America Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Gastrointestinal Candidiasis
7.5.1 Overview
7.5.2 North America Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Genitourinary Tract Candidiasis
7.6.1 Overview
7.6.2 North America Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Systemic Aspergillosis and Systemic Candidiasis Market – Regional Analysis
8.1 Overview
8.1.1 North America: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.2 North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.3 North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
8.1.4 North America Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
8.1.5 US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.1 US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.2 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.5.3 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
8.1.6 Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.1 Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.2 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.6.3 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
8.1.7 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.1 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.2 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.7.3 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
9. Impact of COVID-19 Pandemic on North America Systemic Aspergillosis and Systemic Candidiasis Market
9.1 Impact Assessment of COVID-19 Pandemic
10. COMPANY PROFILES
10.1 Novartis AG
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Sanofi
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Merck & Co., Inc.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bayer AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments2
10.6 Astellas Pharma Inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments6
10.7 GlaxoSmithKline plc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Abbott
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis6
10.8.6 Key Developments
10.9 Cipla Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 Key Developments
10.10 ENZON PHARMACEUTICALS, INC
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix4
11.1 About the Insight Partners
11.2 Glossary of Terms
LIST OF TABLES
Table 1. Clinical Trials Phases of Products Offered by Companies
Table 2. Candida Specific Products
Table 3. Clinical cases of Candida auris reported by U.S. states, as of November 30, 2020
Table 4. North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027
Table 8. Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Glossary of Terms, Systemic Aspergillosis And Systemic Candidiasis Market4
LIST OF FIGURES
Figure 1. Systemic Aspergillosis And Systemic Candidasis Market Segmentation
Figure 2. Systemic Aspergillosis And Systemic Candidasis Market, By Region
Figure 3. North America Systemic Aspergillosis And Systemic Candidasis Market Overview
Figure 4. Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. PEST Analysis
Figure 7. Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint
Figure 8. North America Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)
Figure 9. North America Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 10. North America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)
Figure 15. North America Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 16. North America Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. North America: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 22. North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 23. US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Impact of COVID-19 Pandemic in North American Country Markets
- Novartis AG
- Sanofi
- Pfizer Inc.
- Merck & Co., Inc.
- Bayer AG
- Astellas Pharma Inc.
- GlaxoSmithKline plc.
- Abbott
- Cipla Inc.
- Enzon Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Mar 2021
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Mar 2021
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Mar 2021
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Mar 2021
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Mar 2021
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Mar 2021
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For